
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (36): 4546-4553.DOI: 10.12114/j.issn.1007-9572.2022.0351
Special Issue: 精神卫生最新文章合辑
• Article • Previous Articles Next Articles
Received:2022-04-20
Revised:2022-08-23
Published:2022-12-20
Online:2022-08-26
Contact:
WANG Yanfang
About author:
通讯作者:
王彦芳
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0351
| 组别 | 例数 | 性别〔n(%)〕 | 年龄〔M(P25,P75),岁〕 | 受教育年限〔M(P25,P75),年〕 | |
|---|---|---|---|---|---|
| 男 | 女 | ||||
| 对照组 | 35 | 17(48.6) | 18(51.4) | 31(28,35) | 15(14,16) |
| ASD+MD-组 | 78 | 23(29.5) | 55(70.5) | 34(27,40) | 14(9,15) |
| ASD-MD+组 | 46 | 23(50.0) | 23(50.0) | 27(21,31)a | 15(11,15) |
| ASD+MD+组 | 61 | 23(37.7) | 38(62.3) | 29(22,42) | 14(11,15) |
| ASD-MD-组 | 24 | 4(16.7) | 20(83.3) | 25(21,35) | 14(13,15) |
| H(χ2)值 | 11.517b | 17.003 | 10.394 | ||
| P值 | 0.021 | 0.002 | 0.034 | ||
Table 1 Comparison of basic characteristics of major depressive disorder patients with different subtypes and healthy controls
| 组别 | 例数 | 性别〔n(%)〕 | 年龄〔M(P25,P75),岁〕 | 受教育年限〔M(P25,P75),年〕 | |
|---|---|---|---|---|---|
| 男 | 女 | ||||
| 对照组 | 35 | 17(48.6) | 18(51.4) | 31(28,35) | 15(14,16) |
| ASD+MD-组 | 78 | 23(29.5) | 55(70.5) | 34(27,40) | 14(9,15) |
| ASD-MD+组 | 46 | 23(50.0) | 23(50.0) | 27(21,31)a | 15(11,15) |
| ASD+MD+组 | 61 | 23(37.7) | 38(62.3) | 29(22,42) | 14(11,15) |
| ASD-MD-组 | 24 | 4(16.7) | 20(83.3) | 25(21,35) | 14(13,15) |
| H(χ2)值 | 11.517b | 17.003 | 10.394 | ||
| P值 | 0.021 | 0.002 | 0.034 | ||
| 组别 | 例数 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 |
|---|---|---|---|---|---|---|---|
| 对照组 | 35 | 1(0,3) | 0(0,1) | 0(0,0) | 0(0,0) | 0(0,1) | 0(0,1) |
| ASD+MD-组 | 78 | 21(19,24)ad | 7.5(7,8)acd | 0(0,1)a | 3(2,4)a | 6(5,7)a | 4(3,5)a |
| ASD-MD+组 | 46 | 18(17,19)a | 5(5,6)a | 0(0,1) | 3(2,4)a | 6(5,7)a | 4(3,5)a |
| ASD+MD+组 | 61 | 23(20,26)abc | 8(7,9)abc | 0(0,2)abc | 4(3,5)ab | 6(6,8)a | 4(3,5)a |
| ASD-MD-组 | 24 | 17(17,23)a | 6(5,7)a | 0(0,0) | 4(3,4)a | 6(5,7)a | 4(2,5)a |
| H值 | 128.060 | 179.152 | 30.505 | 96.164 | 96.285 | 63.782 | |
| P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
Table 2 Comparison of the scores of HAMD-17 across major depressive disorder patients with different subtypes and healthy controls
| 组别 | 例数 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 |
|---|---|---|---|---|---|---|---|
| 对照组 | 35 | 1(0,3) | 0(0,1) | 0(0,0) | 0(0,0) | 0(0,1) | 0(0,1) |
| ASD+MD-组 | 78 | 21(19,24)ad | 7.5(7,8)acd | 0(0,1)a | 3(2,4)a | 6(5,7)a | 4(3,5)a |
| ASD-MD+组 | 46 | 18(17,19)a | 5(5,6)a | 0(0,1) | 3(2,4)a | 6(5,7)a | 4(3,5)a |
| ASD+MD+组 | 61 | 23(20,26)abc | 8(7,9)abc | 0(0,2)abc | 4(3,5)ab | 6(6,8)a | 4(3,5)a |
| ASD-MD-组 | 24 | 17(17,23)a | 6(5,7)a | 0(0,0) | 4(3,4)a | 6(5,7)a | 4(2,5)a |
| H值 | 128.060 | 179.152 | 30.505 | 96.164 | 96.285 | 63.782 | |
| P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 |
|---|---|---|---|---|---|---|---|
| 对照组 | 35 | 106(94,109) | 105(102,105) | 112(108,112) | 125(115,125) | 101(101,105) | 545(525,552) |
| ASD+MD-组 | 78 | 83(73,87)a | 102(92,107)a | 96(87,101)a | 106(96,109)a | 85(81,99)a | 471(432,489)a |
| ASD-MD+组 | 46 | 87(78,94)a | 102(90,109)a | 92(79,101)a | 106(102,112)a | 97(70,99)a | 481(446,493)a |
| ASD+MD+组 | 61 | 81(69,83)ab | 100(100,109)a | 96(87,100)a | 112(100,112)a | 97(78,100)a | 493(419,495)a |
| ASD-MD-组 | 24 | 76(76,90)a | 100(92,105)a | 92(74,100)a | 103(100,125)a | 91(83,97)a | 451(426,515)a |
| H值 | 70.772 | 10.218 | 55.575 | 41.135 | 48.796 | 77.545 | |
| P值 | 0.000 | 0.037 | 0.000 | 0.000 | 0.000 | 0.000 |
Table 3 Comparison of the scores of RBANS across major depressive disorder patients with different subtypes and healthy controls
| 组别 | 例数 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 |
|---|---|---|---|---|---|---|---|
| 对照组 | 35 | 106(94,109) | 105(102,105) | 112(108,112) | 125(115,125) | 101(101,105) | 545(525,552) |
| ASD+MD-组 | 78 | 83(73,87)a | 102(92,107)a | 96(87,101)a | 106(96,109)a | 85(81,99)a | 471(432,489)a |
| ASD-MD+组 | 46 | 87(78,94)a | 102(90,109)a | 92(79,101)a | 106(102,112)a | 97(70,99)a | 481(446,493)a |
| ASD+MD+组 | 61 | 81(69,83)ab | 100(100,109)a | 96(87,100)a | 112(100,112)a | 97(78,100)a | 493(419,495)a |
| ASD-MD-组 | 24 | 76(76,90)a | 100(92,105)a | 92(74,100)a | 103(100,125)a | 91(83,97)a | 451(426,515)a |
| H值 | 70.772 | 10.218 | 55.575 | 41.135 | 48.796 | 77.545 | |
| P值 | 0.000 | 0.037 | 0.000 | 0.000 | 0.000 | 0.000 |
| 组别 | 例数 | 潜伏期( | 波幅( | ||||
|---|---|---|---|---|---|---|---|
| Fz | Cz | Pz | Fz | Cz | Pz | ||
| 对照组 | 35 | 396.97±39.11 | 397.43±38.64 | 379.83±30.93 | 2.50±1.75 | 1.94±1.49 | 2.17±2.40 |
| ASD+MD-组 | 78 | 392.87±38.10 | 394.04±37.42 | 392.86±33.78 | 2.75±2.09 | 2.24±1.44 | 2.33±2.60 |
| ASD-MD+组 | 46 | 389.18±38.09 | 383.73±33.13 | 379.78±29.64 | 2.30±1.79 | 2.10±1.66 | 2.04±1.58 |
| ASD+MD+组 | 61 | 393.15±35.25 | 394.21±36.81 | 387.72±32.89 | 2.10±1.57 | 1.96±1.52 | 2.27±1.79 |
| ASD-MD-组 | 24 | 388.25±40.22 | 392.54±41.84 | 387.67±34.25 | 2.65±1.61 | 2.73±1.75 | 2.59±2.33 |
| F值 | F组别=1.458,F电极点=2.369,F交互=0.552 | F组别=1.740,F电极点=1.094,F交互=0.361 | |||||
| P值 | P组别=0.213,P电极点=0.094,P交互=0.817 | P组别=0.139,P电极点=0.335,P交互=0.941 | |||||
Table 4 Comparison of amplitude and latency of N400 across major depressive disorder patients with different subtypes and healthy controls
| 组别 | 例数 | 潜伏期( | 波幅( | ||||
|---|---|---|---|---|---|---|---|
| Fz | Cz | Pz | Fz | Cz | Pz | ||
| 对照组 | 35 | 396.97±39.11 | 397.43±38.64 | 379.83±30.93 | 2.50±1.75 | 1.94±1.49 | 2.17±2.40 |
| ASD+MD-组 | 78 | 392.87±38.10 | 394.04±37.42 | 392.86±33.78 | 2.75±2.09 | 2.24±1.44 | 2.33±2.60 |
| ASD-MD+组 | 46 | 389.18±38.09 | 383.73±33.13 | 379.78±29.64 | 2.30±1.79 | 2.10±1.66 | 2.04±1.58 |
| ASD+MD+组 | 61 | 393.15±35.25 | 394.21±36.81 | 387.72±32.89 | 2.10±1.57 | 1.96±1.52 | 2.27±1.79 |
| ASD-MD-组 | 24 | 388.25±40.22 | 392.54±41.84 | 387.67±34.25 | 2.65±1.61 | 2.73±1.75 | 2.59±2.33 |
| F值 | F组别=1.458,F电极点=2.369,F交互=0.552 | F组别=1.740,F电极点=1.094,F交互=0.361 | |||||
| P值 | P组别=0.213,P电极点=0.094,P交互=0.817 | P组别=0.139,P电极点=0.335,P交互=0.941 | |||||
| 变量 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
| Fz-L | 0.052 | 0.467 | 0.100 | 0.159 | 0.136 | 0.055 | -0.020 | 0.783 | 0.073 | 0.303 | -0.081 | 0.252 |
| Fz-V | -0.074 | 0.299 | -0.090 | 0.202 | -0.021 | 0.765 | -0.170 | 0.016 | 0.111 | 0.118 | -0.015 | 0.830 |
| Cz-L | 0.075 | 0.291 | 0.085 | 0.232 | 0.113 | 0.110 | 0.024 | 0.737 | 0.033 | 0.638 | -0.008 | 0.909 |
| Cz-V | -0.033 | 0.642 | -0.119 | 0.092 | -0.090 | 0.204 | -0.098 | 0.168 | 0.151 | 0.033 | 0.041 | 0.560 |
| Pz-L | 0.025 | 0.724 | 0.067 | 0.343 | 0.046 | 0.514 | -0.041 | 0.567 | 0.026 | 0.718 | -0.012 | 0.861 |
| Pz-V | 0.122 | 0.085 | 0.065 | 0.362 | -0.035 | 0.626 | 0.062 | 0.383 | 0.174 | 0.014 | 0.040 | 0.573 |
Table 5 Correlation of N400 with the total score of HAMD-17 and its factor scores in major depressive disorder patients
| 变量 | HAMD-17总分 | 焦虑/躯体化 | 体质量 | 认知障碍 | 阻滞 | 睡眠障碍 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
| Fz-L | 0.052 | 0.467 | 0.100 | 0.159 | 0.136 | 0.055 | -0.020 | 0.783 | 0.073 | 0.303 | -0.081 | 0.252 |
| Fz-V | -0.074 | 0.299 | -0.090 | 0.202 | -0.021 | 0.765 | -0.170 | 0.016 | 0.111 | 0.118 | -0.015 | 0.830 |
| Cz-L | 0.075 | 0.291 | 0.085 | 0.232 | 0.113 | 0.110 | 0.024 | 0.737 | 0.033 | 0.638 | -0.008 | 0.909 |
| Cz-V | -0.033 | 0.642 | -0.119 | 0.092 | -0.090 | 0.204 | -0.098 | 0.168 | 0.151 | 0.033 | 0.041 | 0.560 |
| Pz-L | 0.025 | 0.724 | 0.067 | 0.343 | 0.046 | 0.514 | -0.041 | 0.567 | 0.026 | 0.718 | -0.012 | 0.861 |
| Pz-V | 0.122 | 0.085 | 0.065 | 0.362 | -0.035 | 0.626 | 0.062 | 0.383 | 0.174 | 0.014 | 0.040 | 0.573 |
| 变量 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
| Fz-L | 0.078 | 0.274 | -0.075 | 0.290 | -0.076 | 0.284 | 0.030 | 0.668 | -0.023 | 0.749 | 0.005 | 0.943 |
| Fz-V | 0.138 | 0.050 | -0.057 | 0.425 | 0.052 | 0.462 | 0.050 | 0.483 | -0.036 | 0.612 | 0.054 | 0.449 |
| Cz-L | -0.020 | 0.774 | -0.066 | 0.349 | -0.119 | 0.094 | -0.073 | 0.306 | -0.155 | 0.028 | -0.135 | 0.055 |
| Cz-V | -0.057 | 0.425 | -0.075 | 0.288 | -0.052 | 0.467 | -0.094 | 0.186 | -0.113 | 0.112 | -0.097 | 0.173 |
| Pz-L | -0.026 | 0.716 | -0.057 | 0.425 | 0.022 | 0.758 | -0.070 | 0.320 | -0.045 | 0.527 | -0.033 | 0.639 |
| Pz-V | 0.018 | 0.799 | -0.050 | 0.484 | -0.015 | 0.833 | -0.053 | 0.454 | -0.033 | 0.644 | -0.039 | 0.581 |
Table 6 Correlation of N400 with the total score of RBANS and its factor scores in major depressive disorder patients
| 变量 | 即刻记忆 | 视觉广度 | 言语功能 | 注意 | 延时记忆 | RBANS总分 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
| Fz-L | 0.078 | 0.274 | -0.075 | 0.290 | -0.076 | 0.284 | 0.030 | 0.668 | -0.023 | 0.749 | 0.005 | 0.943 |
| Fz-V | 0.138 | 0.050 | -0.057 | 0.425 | 0.052 | 0.462 | 0.050 | 0.483 | -0.036 | 0.612 | 0.054 | 0.449 |
| Cz-L | -0.020 | 0.774 | -0.066 | 0.349 | -0.119 | 0.094 | -0.073 | 0.306 | -0.155 | 0.028 | -0.135 | 0.055 |
| Cz-V | -0.057 | 0.425 | -0.075 | 0.288 | -0.052 | 0.467 | -0.094 | 0.186 | -0.113 | 0.112 | -0.097 | 0.173 |
| Pz-L | -0.026 | 0.716 | -0.057 | 0.425 | 0.022 | 0.758 | -0.070 | 0.320 | -0.045 | 0.527 | -0.033 | 0.639 |
| Pz-V | 0.018 | 0.799 | -0.050 | 0.484 | -0.015 | 0.833 | -0.053 | 0.454 | -0.033 | 0.644 | -0.039 | 0.581 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
刘耀中,柳昀哲,林碗君,等. 抑郁障碍的核心脑机制——基于fMRI元分析的证据[J]. 中国科学:生命科学,2015,45(12):1214-1223. DOI:10.1360/N052015-00164.
|
| [6] |
|
| [7] |
王彦芳,杜巧荣,李素萍,等. 伴发睡眠障碍首发抑郁症认知功能损害及影响因素分析[J]. 中国神经精神疾病杂志,2015,41(2):71-75. DOI:10.3936/j.issn.1002-0152.2015.02.002.
|
| [8] |
|
| [9] |
张向红,马宁. 抑郁症严重程度与认知功能及事件相关电位的相关性分析[J]. 国际精神病学杂志,2021,48(6):997-1000. DOI:10.13479/j.cnki.jip.2021.06.011.
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
王玮,钱绍文,刘锴,等. 广泛性焦虑障碍发病机制的静息态功能磁共振成像[J]. 中国医学影像技术,2016,32(3):358-362.
|
| [14] |
|
| [15] | |
| [16] |
|
| [17] |
王勇,赵雅娟,赵国庆,等. 双相抑郁与首发抑郁症汉语成语N400的对照研究[J]. 精神医学杂志,2017,30(6):405-409. DOI:10.3877/cma.j.issn.1674-0785.2012.11.031.
|
| [18] |
聂所成,王娟,刘畅. 老年抑郁症患者的认知功能与事件相关电位N400的表现[J]. 中国老年学杂志,2016,36(24):6209-6210. DOI:10.3969/j.issn.1005-9202.2016.24.078.
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
王勇,陈兴时,楼翡璎,等. 首发抑郁症患者新事件相关电位汉语成语N400的试验研究[J]. 中华临床医师杂志(电子版),2012,6(11):2966-2969. DOI:10.3877/cma.j.issn.1674-0785.2012.11.031.
|
| [1] | NIE Jiahui, LI Guojuan, HAO Zhuoqun, DU Qiaorong, LIU Penghong, LIU Zhifen, LIU Sha, ZHANG Aixia, WANG Yanfang. Heterogeneity and Influencing Factors of Cognitive Function Impairment in Patients with Major Depressive Disorder [J]. Chinese General Practice, 2026, 29(17): 2340-2346. |
| [2] | ZHANG Qi, HE Shen, LI Hua. Interpretation of Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement 2022 [J]. Chinese General Practice, 2025, 28(15): 1823-1830. |
| [3] | FAN Haojie, LIU Lewei, XIA Lei, TIAN Yinghan, YANG Cheng, HAO Mingru, ZHAO Xin, SHEN Qingqing, MO Daming, GENG Feng, LIU Huanzhong. Correlation of Non-suicidal Self-injury with 25-Hydroxyvitamin D3 and Blood Lipid Levels in Adolescents with Major Depressive Disorder [J]. Chinese General Practice, 2025, 28(05): 612-618. |
| [4] | LI Xingjun, LI Shuangrong, WANG Nan, WANG Xiangyu, CUI Ruomei, XU Jian, GUO Yulong, LIU Shuang. Clinical Characteristics of Patients with Idiopathic Inflammatory Myopathy and Risk Factors for the Development of Interstitial Lung Disease [J]. Chinese General Practice, 2024, 27(13): 1623-1629. |
| [5] | DU Yeming, ZHANG Yunqiao, WANG Zongqi, MIN Xue, CUI Yalian, WANG Yanfang. Characteristics of Somatic Symptoms and Their Correlations with Brain-derived Neurotrophic Factor and Inflammatory Cytokinesin Patients with Major Depressive Disorder [J]. Chinese General Practice, 2023, 26(12): 1463-1471. |
| [6] | Yu WU, Jue LIU, Min LIU, Wannian LIANG. Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5 [J]. Chinese General Practice, 2022, 25(30): 3721-3725. |
| [7] | Fangyi DENG, Rui TANG, Liqing ZHANG, Yixian CAI, Rong PAN, Jiyang PAN. Clinical Subtypes and Significanceof Adult Insomnia Disorders [J]. Chinese General Practice, 2022, 25(14): 1667-1673,1693. |
| [8] | QIU Jian,CHENG Jinxiang1REN Jiafeng,SUN Shuyu,ZHAO Xianchao,JIANG Yingcong,SU Changjun. The Latent Class of Clinical Subtypes of Obstructive Sleep Apnea and the Analysis of Characteristics of Initial Exposure to CPAP Therapy [J]. Chinese General Practice, 2021, 24(14): 1745-1751. |
| [9] | LOU Yue,QIAO Song,WANG Yanwen,CAI Miao,ZHUANG Liying,LIU Xiaoli. #br# Non-motor Symptoms in Early Parkinson's Disease with Three Different Motor Subtypes [J]. Chinese General Practice, 2021, 24(12): 1487-1493. |
| [10] | YANG Chenghui,ZHOU Bo,ZHOU Fan,PAN Shuya,WANG Luyao,ZHONG Xuemei,HUANG Yulan,WANG Jinyu. Illness Perception in Patients with Somatic Symptom Disorder:Analysis of Current Status and Influential Factors [J]. Chinese General Practice, 2020, 23(32): 4039-4046. |
| [11] | ZHANG Jinpeng,LI Xue,TAN Xi,DU Jian,ZHAO Mingyang,YOU Mingyan,ZHANG Yichunzi,KONG Junhui. Emotional Cognitive Impairment Regulated by Happy Emotional Induction in People with Subthreshold Depression:an Event-related Potential Study [J]. Chinese General Practice, 2019, 22(35): 4312-4317. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||